← Back to headlines
Bayer’s AskBio Completes Enrollment in Phase 2 Heart Failure Gene Therapy Trial
The biotechnology division of Bayer has finished patient enrollment for a clinical trial testing a new gene therapy aimed at treating heart failure.
30 Aug, 20:01 — 30 Aug, 20:01
Sources
Showing 1 of 1 sources
